View of A REVIEW ON GLIMEPIRIDE VS TENELIGLIPTIN AS A SECOND-LINE DRUG FOR THE TREATMENT OF TYPE 2 DIABETES MELLITUS | JOURNAL OF EDUCATION AND SCIENTIFIC MEDICINE